MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-56-0023273
Lucrose Pharma Private Limited - pharma in Meerut, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹22.61 Cr
▲ 10% YoY
Net profit · FY 2025
₹43.44 Lakh
Net margin 1.9%
EBITDA · FY 2025
₹88.81 Lakh
EBITDA margin 3.9%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Employees · EPFO
186
Provident fund records
Directors on board
5
As per MCA filings
About Lucrose Pharma Private Limited
Data last updated:
Lucrose Pharma Private Limited is a private limited company based in Meerut, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2016PTC084888. Its GSTIN is 09AADCL1215G1ZV (Uttar Pradesh).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Dinesh Kumar and Anita Singh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Part Of Plot No 7 Tirupati Industrial Estate Mohkampur, Meerut, Uttar Pradesh, India – 250002.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.61 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹43.44 Lakh (net margin 1.9%) and EBITDA of ₹88.81 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 23% over five years.
The company has about 186 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lucrose Pharma. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 3 cases are pending.
Lucrose Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-56-0023273). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lucrosepharma.co.in.
Company details
CIN U74999UP2016PTC084888
Registration Number 084888
Incorporation Date 14 July 2016
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-56-0023273
Recognitions & Rankings of Lucrose Pharma
Contact details
Lucrose Pharma Private Limited's registered office is in Meerut, Uttar Pradesh. Its website is lucrosepharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPart Of Plot No 7 Tirupati Industrial Estate Mohkampur, Meerut, Uttar Pradesh, India – 250002
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Lucrose Pharma Private Limited, buy the company report.
Comprehensive company report
Lucrose Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Lucrose Pharma operates one associated brand: Lucrose Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and diagnostic services in India. | lucrosepharma.com |
Business activity
The main business activity of Lucrose Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lucrose Pharma Private Limited, buy the company report.
Financials of Lucrose Pharma Private Limited
FY 2024 filings availableLucrose Pharma Private Limited reported revenue of ₹22.61 Cr (up 10% YoY) for FY 2025.
Revenue · FY 2025
₹22.61 Cr ▲ 10%
Net profit · FY 2025
₹43.44 Lakh margin 1.9%
EBITDA · FY 2025
₹88.81 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 15%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 20%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 10% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹88.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹43.44 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lucrose Pharma Private Limited, buy the company report.
Board of directors of Lucrose Pharma Private Limited
Lucrose Pharma has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Kumar | Director | 14 Jul 2016 | 10 Years 3 Months | Current |
| Anita Singh Also directs: Diggal Pharma Private Limited | Director | 08 Aug 2021 | 5 Years 2 Months | Current |
| Gajendra Singh | Director | 14 Jul 2016 | 10 Years 3 Months | Current |
| Amit Verma | Director | 05 Oct 2021 | 5 Years 0 Months | Current |
| Pawan Pandey Also directs: Diggal Pharma Private Limited | Director | 10 May 2025 | 1 Years 5 Months | Current |
Peer comparison
Lucrose Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bareilly Pharmaceuticals Private Limited | ₹22.81 Cr (FY 2024) | 7.0% | Bareilly, Uttar Pradesh, India | |||
| Hexa Health Care Private Limited | ₹22.74 Cr (FY 2025) | 37.0% | Mumbai, Maharashtra, India | |||
| Advanov Pharma Private Limited | ₹22.68 Cr (FY 2024) | 107.0% | Ahmedabad, Gujarat, India | |||
| Avis Lifecare Private Limited | ₹22.66 Cr (FY 2025) | -4.0% | Jaipur, Rajasthan, India | |||
| Lucrose Pharma Private Limitedthis company | ₹22.61 Cr (FY 2025) | ₹43.44 Lakh | 1.9% | 10.0% | 186 | Meerut, Uttar Pradesh, India |
| Pharmadude Pharmacies Private Limited | ₹22.61 Cr (FY 2025) | 22.0% | Vaduthala, Kerala, India | |||
| Sethi Pharma Distributors Private Limited | ₹22.59 Cr (FY 2025) | -7.0% | Rewa, Madhya Pradesh, India | |||
| Celera Pharma Private Limited | ₹22.48 Cr (FY 2025) | 23.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Lucrose Pharma Private Limited, buy the company report.
Auditor
Lucrose Pharma Private Limited is audited by VIKAS & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS & CO. | FY 2023 | 0004940C |
Shareholding
The shareholding of Lucrose Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lucrose Pharma Private Limited, buy the company report.
Legal cases
Lucrose Pharma Private Limited has 7 court cases on record: 3 filed by Lucrose Pharma, 4 filed against it. 3 cases are pending and 4 are disposed.
Total cases
7
Filed by the company
3
Filed against the company
4
Pending
3
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 4 | 1 |
| High courts | 2 | 0 | 2 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Meerut, Uttar Pradesh | Criminal case | Filed by the company against an individual | Pending |
| High Court of Delhi | Court case (C.O. (COMM.IPD-TM)) | Filed by the company against The Registrar of Trade Marks Baudhik Sampada Bhawan & Anr. | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against an individual | Pending |
| District court, Hapur, Uttar Pradesh | Court case (Motor Vehicle Act) | Filed against the company by State of U.P. | Disposed |
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
To see the full case history of Lucrose Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lucrose Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Lucrose Pharma has 2 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Associated companies
Employees & EPFO
Lucrose Pharma Private Limited has a workforce of 186 employees on its EPFO records as of Apr 10, 2024, across 1 active EPFO establishment.
Employee count
186
Active EPFO establishments
1
Employee growth
-27.06%
GST
Lucrose Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCL1215G1ZV | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lucrose Pharma Private Limited, buy the company report.
Recent activity
Lucrose Pharma Private Limited has 15 board changes on record since 2016: 5 appointments and 10 cessations. The latest: Pawan Pandey ceased to be Additional Director on 29 Sep 2025.
Ceased
Pawan Pandey ceased to be Additional Director.
Appointed
Pawan Pandey was appointed as Director.
AGM
Lucrose Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Lucrose Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Ceased
Amit Verma ceased to be Additional Director.
Ceased
Sanjay Rajora ceased to be Director.
Ceased
Sunil Kumar ceased to be Director.
Appointed
Amit Verma was appointed as Director.
Appointed
Anita Singh was appointed as Director.
Ceased
Anupam Kaushik ceased to be Director.
Ceased
Kusum Shah ceased to be Director.
Ceased
Priti ceased to be Director.
6 earlier events are in the company report.
Frequently asked questions
Lucrose Pharma is an active private limited company based in Meerut, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 July 2016 (10+ years old) and is registered under CIN U74999UP2016PTC084888.
Lucrose Pharma has 5 current directors:
- Dinesh Kumar - Director
- Anita Singh - Director
- Gajendra Singh - Director
- Amit Verma - Director
- Pawan Pandey - Director
The latest financial statements of Lucrose Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Lucrose Pharma is 09AADCL1215G1ZV, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Lucrose Pharma is U74999UP2016PTC084888. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lucrose Pharma has 7 court cases on record: 3 filed by the company and 4 filed against it. 3 are pending. Most are in the district courts.
Lucrose Pharma was incorporated on 14 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Lucrose Pharma by revenue are Bareilly Pharmaceuticals Private Limited, Hexa Health Care Private Limited, Advanov Pharma Private Limited, Avis Lifecare Private Limited, Pharmadude Pharmacies Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Pawan Pandey ceased to be Additional Director on 29 Sep 2025. Pawan Pandey was appointed as Director on 10 May 2025. Amit Verma ceased to be Additional Director on 29 Sep 2023. Lucrose Pharma has 15 board changes on record in total.
Yes, Lucrose Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-UP-56-0023273).
Lucrose Pharma can be reached through the website lucrosepharma.co.in. Its registered office is in Meerut, Uttar Pradesh, India.